Methotrexate (Mylan Institutional LLC)


Welcome to the PulseAid listing for the Methotrexate drug offered from Mylan Institutional LLC. This Folate Analog Metabolic Inhibitor [EPC],Folic Acid Metabolism Inhibitors [MoA] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
LABELER NAME / MANUFACTURER: Mylan Institutional LLC
NON-PROPRIETARY NAME: Methotrexate
SUBSTANCE NAME: METHOTREXATE
TYPE: HUMAN PRESCRIPTION DRUG
PHARMA CLASS: Folate Analog Metabolic Inhibitor [EPC],Folic Acid Metabolism Inhibitors [MoA]
ROUTE: INTRA-ARTERIAL; INTRAMUSCULAR; INTRATHECAL; INTRAVENOUS
DOSAGE FORM: INJECTION, SOLUTION
MARKETING CATEGORY NAME: ANDA
START MARKETING DATE: 2012-06-27
END MARKETING DATE: 0000-00-00


Methotrexate HUMAN PRESCRIPTION DRUG Details:

Item DescriptionMethotrexate from Mylan Institutional LLC
LABELER NAME: Mylan Institutional LLC
DEA SCHEDULE:
ACTIVE STRENGTH: 1(g/40mL)
START MARKETING DATE: 2012-06-27
END MARKETING DATE: 0000-00-00
PRODUCT ID: 67457-221_314a6af2-e75d-4dfe-a944-8298d03db6c2
PRODUCT NDC: 67457-221
APPLICATION NUMBER: ANDA040716

Other METHOTREXATE Pharmaceutical Manufacturers / Labelers:

Manufacturer / LabelerProprietary Name
Accord Healthcare, Inc.Methotrexate
Antares Pharma, Inc.Otrexup
Cadila Healthcare LimitedMethotrexate
Mylan Institutional LLCMethotrexate
Pfizer Laboratories Div Pfizer Inc.Methotrexate
Physicians Total Care, Inc.METHOTREXATE
Silvergate Pharmaceuticals, Inc.Xatmep
West-Ward Pharmaceuticals CorpMethotrexate
Zydus Pharmaceuticals (USA) Inc.Methotrexate